Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma

BACKGROUND: Metastatic melanoma is an aggressive skin cancer with a poor prognosis. Current treatment strategies for high-stage melanoma are based around the use of immunotherapy with immune checkpoint inhibitors such as anti-PDL1 or anti-CTLA4 antibodies to stimulate anti-cancer T cell responses, y...

Descripción completa

Detalles Bibliográficos
Autores principales: De Santo, Carmela, Cheng, Paul, Beggs, Andrew, Egan, Sharon, Bessudo, Alberto, Mussai, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960181/
https://www.ncbi.nlm.nih.gov/pubmed/29776373
http://dx.doi.org/10.1186/s13045-018-0612-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960181/
https://www.ncbi.nlm.nih.gov/pubmed/29776373
http://dx.doi.org/10.1186/s13045-018-0612-6

Ejemplares similares